{"id":"https://openalex.org/W4361947290","doi":"https://doi.org/10.1158/1078-0432.c.6530279","title":"Data from Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity","display_name":"Data from Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361947290","doi":"https://doi.org/10.1158/1078-0432.c.6530279"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6530279","doi":"https://doi.org/10.1158/1078-0432.c.6530279","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6530279","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6530279","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064151962","display_name":"Shipra Gandhi","orcid":"https://orcid.org/0000-0003-3506-0284","observed_orcids":["https://orcid.org/0000-0003-3506-0284"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Shipra Gandhi","raw_affiliation_strings":["Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089941327","display_name":"Manu Raj Pandey","orcid":"https://orcid.org/0000-0002-5276-3806","observed_orcids":["https://orcid.org/0000-0002-5276-3806"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manu R. Pandey","raw_affiliation_strings":["Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011054139","display_name":"Kristopher M. Attwood","orcid":"https://orcid.org/0000-0002-7229-5472","observed_orcids":["https://orcid.org/0000-0002-7229-5472","https://orcid.org/0009-0003-3874-1293"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristopher Attwood","raw_affiliation_strings":["Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Wenyan Ji","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wenyan Ji","raw_affiliation_strings":["Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034535391","display_name":"Agnieszka Katarzyna Witkiewicz","orcid":"https://orcid.org/0000-0003-4538-1145","observed_orcids":["https://orcid.org/0000-0003-4538-1145"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Agnieszka K. Witkiewicz","raw_affiliation_strings":["Center for Per-sonalized Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Per-sonalized Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029801038","display_name":"Erik S. Knudsen","orcid":"https://orcid.org/0000-0002-5130-5969","observed_orcids":["https://orcid.org/0000-0002-5130-5969"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erik S. Knudsen","raw_affiliation_strings":["Center for Per-sonalized Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York"],"raw_orcid":"https://orcid.org/0000-0002-5130-5969","affiliations":[{"raw_affiliation_string":"Center for Per-sonalized Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110967141","display_name":"Cheryl L. Allen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cheryl Allen","raw_affiliation_strings":["Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053887896","display_name":"Joseph Dennis Tario","orcid":"https://orcid.org/0009-0009-2145-6617","observed_orcids":["https://orcid.org/0009-0009-2145-6617"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph D. Tario","raw_affiliation_strings":["Department of Flow Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Flow Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065404552","display_name":"Paul K. Wallace","orcid":"https://orcid.org/0000-0001-7823-9917","observed_orcids":["https://orcid.org/0000-0001-7823-9917"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul K. Wallace","raw_affiliation_strings":["Department of Flow Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Flow Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109602063","display_name":"Carlos D. Cedeno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carlos D. Cedeno","raw_affiliation_strings":["Department of Flow Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Flow Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058935510","display_name":"Maria Levis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria Levis","raw_affiliation_strings":["Clinical Research Service, Roswell Park Comprehensive Cancer Center, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Service, Roswell Park Comprehensive Cancer Center, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078413773","display_name":"Suzanne M. Stack","orcid":"https://orcid.org/0000-0003-4256-8035","observed_orcids":["https://orcid.org/0000-0003-4256-8035"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suzanne Stack","raw_affiliation_strings":["Clinical Research Service, Roswell Park Comprehensive Cancer Center, Buffalo, New York"],"raw_orcid":"https://orcid.org/0000-0003-4256-8035","affiliations":[{"raw_affiliation_string":"Clinical Research Service, Roswell Park Comprehensive Cancer Center, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057402683","display_name":"Pauline Funchain","orcid":"https://orcid.org/0000-0002-7568-8626","observed_orcids":["https://orcid.org/0000-0002-7568-8626"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pauline Funchain","raw_affiliation_strings":["Department of Hema-tology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hema-tology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018176156","display_name":"Joseph J. Drabick","orcid":"https://orcid.org/0000-0002-7630-2721","observed_orcids":["https://orcid.org/0000-0002-7630-2721"]},"institutions":[{"id":"https://openalex.org/I4405268258","display_name":"Penn State Cancer Institute","ror":"https://ror.org/00bzx1854","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4405268258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph J. Drabick","raw_affiliation_strings":["Division of Hematology and Oncology, Penn State Cancer Institute, Hershey, Pennsyl-vania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Penn State Cancer Institute, Hershey, Pennsyl-vania","institution_ids":["https://openalex.org/I4405268258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078984239","display_name":"Mark J. Bucsek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark J. Bucsek","raw_affiliation_strings":["Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049243227","display_name":"Igor J. Puzanov","orcid":"https://orcid.org/0000-0002-9803-3497","observed_orcids":["https://orcid.org/0000-0002-9803-3497"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Igor Puzanov","raw_affiliation_strings":["Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071658240","display_name":"Hemn Mohammadpour","orcid":"https://orcid.org/0000-0002-0158-7283","observed_orcids":["https://orcid.org/0000-0002-0158-7283"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hemn Mohammadpour","raw_affiliation_strings":["Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029344793","display_name":"Elizabeth A. Repasky","orcid":"https://orcid.org/0000-0002-9554-4152","observed_orcids":["https://orcid.org/0000-0002-9554-4152"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth A. Repasky","raw_affiliation_strings":["Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089516753","display_name":"Marc S. Ernstoff","orcid":"https://orcid.org/0000-0002-8132-7069","observed_orcids":["https://orcid.org/0000-0002-8132-7069"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]},{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc S. Ernstoff","raw_affiliation_strings":["Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York","Division of Cancer Treatment and Diagnosis/ Developmental Therapy Program-ImmunoOncology Branch, NIH/NCI, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"Division of Cancer Treatment and Diagnosis/ Developmental Therapy Program-ImmunoOncology Branch, NIH/NCI, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5064151962"],"corresponding_institution_ids":["https://openalex.org/I1292894508"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12626","display_name":"Cancer, Stress, Anesthesia, and Immune Response","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/propranolol","display_name":"propranolol","score":0.9879999756813049},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":1.0},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.984000027179718},{"id":"https://openalex.org/keywords/locally-advanced-melanoma","display_name":"locally advanced melanoma","score":0.9649999737739563},{"id":"https://openalex.org/keywords/beta-adrenergic-signaling","display_name":"beta-adrenergic signaling","score":0.8199999928474426},{"id":"https://openalex.org/keywords/beta2-adrenergic-receptor","display_name":"beta2-adrenergic receptor","score":0.8669999837875366},{"id":"https://openalex.org/keywords/immunosuppressive-tumor-microenvironment","display_name":"immunosuppressive tumor microenvironment","score":0.7860000133514404},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7870000004768372},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.8399999737739563},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7289999723434448},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.8259999752044678},{"id":"https://openalex.org/keywords/recommended-phase-ii-dose","display_name":"recommended phase 2 dose","score":0.8740000128746033},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.8209999799728394},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7739999890327454},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.953000009059906}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8819911479949951},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8419030904769897},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7130345106124878},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6162331104278564},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.6120492815971375},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5569458603858948},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5407363176345825},{"id":"https://openalex.org/C2778151854","wikidata":"https://www.wikidata.org/wiki/Q423364","display_name":"Propranolol","level":2,"score":0.5005128383636475},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4948098063468933},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4333106577396393},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3306991457939148},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32662689685821533},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.225541353225708},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.16720658540725708}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6530279","doi":"https://doi.org/10.1158/1078-0432.c.6530279","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6530279","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6530279","doi":"https://doi.org/10.1158/1078-0432.c.6530279","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6530279","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1010591873","display_name":null,"funder_award_id":"P30 CA016056","funder_id":"https://openalex.org/F4320306497","funder_display_name":"Roswell Park Cancer Institute"},{"id":"https://openalex.org/G520438669","display_name":"Institutional Career Development","funder_award_id":"KL2TR001413","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G6913364651","display_name":"Understanding how adrenergic signaling influences immune contexture of tumors and  the efficacy of checkpoint inhibitors","funder_award_id":"R01CA205246","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7918204433","display_name":"University of Buffalo Clinical and Translational Science Institute","funder_award_id":"UL1TR001412","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000888465","display_name":"Roswell Park Cancer Center Support Grant","funder_award_id":"P30CA016056","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306497","display_name":"Roswell Park Cancer Institute","ror":"https://ror.org/0499dwk57"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1996299251","https://openalex.org/W2014334618","https://openalex.org/W2080886891","https://openalex.org/W2104238008","https://openalex.org/W2132750237","https://openalex.org/W2150740158","https://openalex.org/W2151454086","https://openalex.org/W2284755230","https://openalex.org/W2310090962","https://openalex.org/W2471500324","https://openalex.org/W2535549547","https://openalex.org/W2601000668","https://openalex.org/W2756471028","https://openalex.org/W2768592202","https://openalex.org/W2770445892","https://openalex.org/W2800488493","https://openalex.org/W2807441801","https://openalex.org/W2891638336","https://openalex.org/W2903798211","https://openalex.org/W2913965749","https://openalex.org/W2945293588","https://openalex.org/W2963476376","https://openalex.org/W2991607782","https://openalex.org/W3001043580","https://openalex.org/W3006860517","https://openalex.org/W3043703771","https://openalex.org/W4253964638"],"related_works":["https://openalex.org/W3095647733","https://openalex.org/W4282920778","https://openalex.org/W4232093254","https://openalex.org/W4361939075","https://openalex.org/W4361939064","https://openalex.org/W4362432265","https://openalex.org/W2535549547","https://openalex.org/W4362411452","https://openalex.org/W4313360018","https://openalex.org/W4362411008"],"abstract_inverted_index":{"AbstractPurpose:":[0],"Increased":[1],"\u03b2-adrenergic":[2],"receptor":[3],"(\u03b2-AR)":[4],"signaling":[5,27],"has":[6],"been":[7],"shown":[8,22],"to":[9,55,109,247],"promote":[10],"the":[11,38,64,111],"creation":[12],"of":[13,25,40,66,69,151,155,220],"an":[14,205],"immunosuppressive":[15,49],"tumor":[16,53],"microenvironment":[17],"(TME).":[18],"Preclinical":[19],"studies":[20],"have":[21],"that":[23,36,46],"abrogation":[24],"this":[26],"pathway,":[28],"particularly":[29],"\u03b22-AR,":[30],"provides":[31],"a":[32,70,94,162,210,239],"more":[33],"favorable":[34],"TME":[35],"enhances":[37],"activity":[39],"anti\u2013PD-1":[41],"checkpoint":[42,57],"inhibitors.":[43],"We":[44],"hypothesize":[45],"blocking":[47],"stress-related":[48],"pathways":[50],"would":[51],"improve":[52],"response":[54,135,192],"immune":[56],"inhibitors":[58],"in":[59,76,153,181,200,207,212,216,224,245],"patients.":[60,183],"Here,":[61],"we":[62],"report":[63],"results":[65],"dose":[67,88,115],"escalation":[68,89],"nonselective":[71],"\u03b2-blocker":[72],"(propranolol)":[73],"with":[74,78,96,131,145,222],"pembrolizumab":[75,97,223,248],"patients":[77,130,144],"metastatic":[79,146,226],"melanoma.":[80],"Patients":[81],"and":[82,123,158,178,209,230,253],"Methods:":[83],"A":[84],"3":[85,87,101],"+":[86],"study":[90],"for":[91],"propranolol":[92,152,221],"twice":[93,161,238],"day":[95,240],"(200":[98],"mg":[99,160,237],"every":[100],"weeks)":[102],"was":[103,108,194,214,241],"completed.":[104],"The":[105],"primary":[106],"objective":[107],"determine":[110],"recommended":[112],"phase":[113],"II":[114],"(RP2D).":[116],"Additional":[117],"objectives":[118],"included":[119],"safety,":[120,251],"antitumor":[121,255],"activity,":[122],"biomarker":[124],"analyses.":[125],"Responders":[126],"were":[127,167,175,203],"defined":[128],"as":[129,243],"complete":[132],"or":[133],"partial":[134],"per":[136],"immune-modified":[137],"RECIST":[138],"at":[139],"6":[140],"months.":[141],"Results:":[142],"Nine":[143],"melanoma":[147,227],"received":[148],"increasing":[149],"doses":[150],"cohorts":[154],"10,":[156],"20,":[157],"30":[159,236],"day.":[163],"No":[164],"dose-limiting":[165],"toxicities":[166],"observed.":[168],"Most":[169],"common":[170],"treatment-related":[171],"adverse":[172],"events":[173],"(TRAEs)":[174],"rash,":[176],"fatigue,":[177],"vitiligo,":[179],"observed":[180],"44%":[182],"One":[184],"patient":[185],"developed":[186],"two":[187],"grade":[188],"\u22653":[189],"TRAEs.":[190],"Objective":[191],"rate":[193],"78%.":[195],"While":[196],"no":[197],"significant":[198],"changes":[199],"treatment-associated":[201],"biomarkers":[202],"observed,":[204],"increase":[206],"IFN\u03b3":[208],"decrease":[211],"IL6":[213],"noted":[215],"responders.":[217],"Conclusions:":[218],"Combination":[219],"treatment-na\u00efve":[225],"is":[228],"safe":[229],"shows":[231],"very":[232],"promising":[233],"activity.":[234,256],"Propranolol":[235],"selected":[242],"RP2D":[244],"addition":[246],"based":[249],"on":[250],"tolerability,":[252],"preliminary":[254]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2023-04-05T00:00:00"}